This review focuses on the last decade evidence for a role of four members of the TNFRSF, Fas, TNFR1, LT-βR, and p75NTR in the death of motoneurons in ALS and how this new knowledge could be the basis of new therapeutic approaches in ALS. The gene discussed is LTBR; the disease is amyotrophic lateral sclerosis.